Insights

Innovative Diagnostics Cernostics utilizes a cutting-edge tissue systems biology approach with its proprietary TissueCypher platform, offering highly accurate and comprehensive cancer diagnostics that can appeal to healthcare providers seeking advanced, reliable tumor analysis tools.

Strategic Acquisitions The recent acquisition of Cernostics by TissueCypher for up to 50 million dollars indicates strong investor confidence, opening opportunities to target other similar companies or institutional investors interested in innovative diagnostics platforms.

Partnership Opportunities Cernostics collaborates with TissueCypher for clinical risk-stratification, suggesting potential for expanding partnerships with hospitals, research institutions, and biotech firms focused on personalized cancer treatment and tissue analysis.

Market Potential With a small revenue base and significant growth potential demonstrated by recent investments and collaborations, Cernostics presents a compelling opportunity to offer complementary products or services aimed at precision oncology and diagnostic enhancement.

Growth and Funding Having secured 6 million dollars in funding and being part of a strategic acquisition, Cernostics is positioned for product development and expansion within the biotech diagnostics sector, making it a promising target for stakeholders interested in innovative healthcare technologies.

Cernostics Tech Stack

Cernostics uses 8 technology products and services including W3 Total Cache, OneTrust, MySQL, and more. Explore Cernostics's tech stack below.

  • W3 Total Cache
    Caching
  • OneTrust
    Cookie Compliance
  • MySQL
    Database
  • Choices
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Pardot
    Marketing
  • WP Engine
    Platform As A Service
  • Google Tag Manager
    Tag Management

Cernostics's Email Address Formats

Cernostics uses at least 2 format(s):
Cernostics Email FormatsExamplePercentage
FLast@cernostics.comJDoe@cernostics.com
100%

Frequently Asked Questions

Where is Cernostics's headquarters located?

Minus sign iconPlus sign icon
Cernostics's main headquarters is located at 235 William Pitt Way Pittsburgh, Pennsylvania 15238 United States. The company has employees across 1 continents, including North America.

What is Cernostics's phone number?

Minus sign iconPlus sign icon
You can contact Cernostics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cernostics's official website and social media links?

Minus sign iconPlus sign icon
Cernostics's official website is tissuecypher.com and has social profiles on LinkedInCrunchbase.

What is Cernostics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cernostics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cernostics have currently?

Minus sign iconPlus sign icon
As of March 2026, Cernostics has approximately 11 employees across 1 continents, including North America. Key team members include Vice President Of Marketing: L. B.Senior Associate Scientist And Informatics Lab Manager: L. R.Laboratory Technician: N. P.. Explore Cernostics's employee directory with LeadIQ.

What industry does Cernostics belong to?

Minus sign iconPlus sign icon
Cernostics operates in the Biotechnology Research industry.

What technology does Cernostics use?

Minus sign iconPlus sign icon
Cernostics's tech stack includes W3 Total CacheOneTrustMySQLChoicesjQueryPardotWP EngineGoogle Tag Manager.

What is Cernostics's email format?

Minus sign iconPlus sign icon
Cernostics's email format typically follows the pattern of FLast@cernostics.com. Find more Cernostics email formats with LeadIQ.

How much funding has Cernostics raised to date?

Minus sign iconPlus sign icon
As of March 2026, Cernostics has raised $6M in funding. The last funding round occurred on Aug 13, 2021 for $6M.

Cernostics

Biotechnology ResearchPennsylvania, United States11-50 Employees

Cernostics has joined Castle Biosciences. Please stay connected! 
https://www.linkedin.com/company/castle-biosciences-inc-/

Cernostics is a diagnostics company focused on delivering next generation cancer diagnostics and prognostics through a unique approach to tissue analysis.  

Most current diagnostic approaches offer a limited view of cancer because they fail to evaluate the tumor as a system composed of multiple interacting cell types.

Cernostics takes a tissue systems biology approach to anatomic pathology.  Its patent-protected technology platform, TissueCypher, uniquely analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics.  Learn more about our technology platform [www.cernostics.com] and how it will change the future of cancer diagnostics.

Section iconCompany Overview

Headquarters
235 William Pitt Way Pittsburgh, Pennsylvania 15238 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $6M

    Cernostics has raised a total of $6M of funding over 12 rounds. Their latest funding round was raised on Aug 13, 2021 in the amount of $6M.

  • $1M

    Cernostics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $6M

    Cernostics has raised a total of $6M of funding over 12 rounds. Their latest funding round was raised on Aug 13, 2021 in the amount of $6M.

  • $1M

    Cernostics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.